NCT01658436 2016-05-02BEZ235 Phase II Trial in Patients With Advanced Pancreatic Neuroendocrine Tumors (pNET) After Failure of mTOR Inhibitor Therapy.NovartisPhase 2 Completed31 enrolled 7 charts